The Valley Desk

NCT02019550 · Interventional trial

Rebif® Rebidose® Versus Rebiject II® Ease-of-Use

Overall registry status Completed

Phase 4

Conditions Multiple Sclerosis, Relapsing-Remitting

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov